[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BioCentury BioCentury BioCentury posts on X about novartis, finance, kong, hong kong the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::227778014/interactions)  - X Week XXXXXX +5,008% - X Month XXXXXXX +775% - X Months XXXXXXX +93% - X Year XXXXXXX +18% ### Mentions: X [#](/creator/twitter::227778014/posts_active)  - X Week XX +33% - X Month XX +6.70% - X Months XXX +4.90% - X Year XXX -XXXX% ### Followers: XXXXXX [#](/creator/twitter::227778014/followers)  - X Week XXXXXX +0.58% - X Month XXXXXX +0.87% - X Months XXXXXX +1.60% - X Year XXXXXX +2.70% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::227778014/influencer_rank)  ### Social Influence [#](/creator/twitter::227778014/influence) --- **Social category influence** [finance](/list/finance) XXXX% [stocks](/list/stocks) XXXX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [novartis](/topic/novartis) 1.96%, [finance](/topic/finance) 1.96%, [kong](/topic/kong) 1.96%, [hong kong](/topic/hong-kong) 1.96%, [$192m](/topic/$192m) 1.96%, [money](/topic/money) XXXX% **Top accounts mentioned or mentioned by** [@jeff_cranmer](/creator/undefined) [@sofinnovavcs](/creator/undefined) [@nvidia](/creator/undefined) [@usfdas](/creator/undefined) [@usfda](/creator/undefined) [@pfizer](/creator/undefined) [@flyingeagle86](/creator/undefined) [@lcccc333](/creator/undefined) [@marketwirenews](/creator/undefined) [@fishburnsimone](/creator/undefined) [@akesoinc](/creator/undefined) [@moneyoverhealth](/creator/undefined) **Top assets mentioned** [Novartis AG (NVS)](/topic/novartis) ### Top Social Posts [#](/creator/twitter::227778014/posts) --- Top posts by engagements in the last XX hours "Novartis names Mehta new CFO. Plus: Biontechs chief strategy officer steps down and updates from Vor Vivid Dx in BioCentury's Management Tracks"  [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1946012088293371953) 2025-07-18 01:00:11 UTC 16.2K followers, XXX engagements "Capital flows continue in Asia. Ascentage Pharma raises $192M in Hong Kong placement while Korea-based Illimis raises $XX million in a series B round: BioCentury's latest Finance Report"  [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1946321633376944468) 2025-07-18 21:30:12 UTC 16.3K followers, XXX engagements "Third patient dies from acute liver failure caused by a Sarepta gene therapy"  [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1945996977247793589) 2025-07-18 00:00:08 UTC 16.3K followers, 92.2K engagements "Seed/Series A money up in 1H25 but mostly a few companies raising monster rounds: a BioCentury Data Byte"  [@BioCentury](/creator/x/BioCentury) on [X](/post/tweet/1946291423717863789) 2025-07-18 19:30:10 UTC 16.3K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioCentury posts on X about novartis, finance, kong, hong kong the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance XXXX% stocks XXXX% travel destinations XXXX%
Social topic influence novartis 1.96%, finance 1.96%, kong 1.96%, hong kong 1.96%, $192m 1.96%, money XXXX%
Top accounts mentioned or mentioned by @jeff_cranmer @sofinnovavcs @nvidia @usfdas @usfda @pfizer @flyingeagle86 @lcccc333 @marketwirenews @fishburnsimone @akesoinc @moneyoverhealth
Top assets mentioned Novartis AG (NVS)
Top posts by engagements in the last XX hours
"Novartis names Mehta new CFO. Plus: Biontechs chief strategy officer steps down and updates from Vor Vivid Dx in BioCentury's Management Tracks" @BioCentury on X 2025-07-18 01:00:11 UTC 16.2K followers, XXX engagements
"Capital flows continue in Asia. Ascentage Pharma raises $192M in Hong Kong placement while Korea-based Illimis raises $XX million in a series B round: BioCentury's latest Finance Report" @BioCentury on X 2025-07-18 21:30:12 UTC 16.3K followers, XXX engagements
"Third patient dies from acute liver failure caused by a Sarepta gene therapy" @BioCentury on X 2025-07-18 00:00:08 UTC 16.3K followers, 92.2K engagements
"Seed/Series A money up in 1H25 but mostly a few companies raising monster rounds: a BioCentury Data Byte" @BioCentury on X 2025-07-18 19:30:10 UTC 16.3K followers, XXX engagements
/creator/twitter::BioCentury